⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15722703 | 0.83 | — | — | |
| SCHEMBL126833 | 0.75 | TSHR (0.40) | — | |
| SCHEMBL10001939 | 0.73 | ALDH1A1 (0.36) | — | |
| SCHEMBL5455990 | 0.73 | — | — | |
| SCHEMBL12335884 | 0.73 | CRBN (0.35) | — | |
| SCHEMBL8271652 | 0.72 | — | — | |
| SCHEMBL8006205 | 0.71 | TSHR (0.36) | — | |
| SCHEMBL12706200 | 0.71 | TSHR (0.36) | — | |
| SCHEMBL14191850 | 0.71 | — | — | |
| SCHEMBL22794857 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250361181-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | HSUSTAINABILITY GMBH (DE) | 2025-11-27 | — | — | US | claimed |
| EP-4565543-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | Heidelberg Materials AG (DE) | 2025-06-11 | — | — | EP | claimed |
| CN-118271570-A | Preparation method of organic phosphine-terminated non-conjugated oxygen-enriched fluorescent polymer, and product and application thereof | 浙江大学 | 2024-07-02 | — | — | CN | claimed |
| WO-2024028219-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | HEIDELBERG MATERIALS AG (DE) | 2024-02-08 | — | — | WO | claimed |
| EP-4317103-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | Heidelberg Materials AG (DE) | 2024-02-07 | — | — | EP | claimed |
| EP-4736890-A2 | PROCESS FOR PRODUCTION OF KETOCARBOXYLIC ACID VINYL ESTERS | QuantView GmbH (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4710950-A2 | PROCESS FOR PRODUCTION OF KETOCARBOXYLIC ACID VINYL ESTERS | QuantView GmbH (DE) | 2026-03-18 | — | — | EP | disclosed |
| EP-4702027-A1 | 4-AMINOPYRROLO[2,1-F][1,2,4]TRIAZINE C-NUCLEOSIDE COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. (US) | 2026-03-04 | — | — | EP | disclosed |
| US-12544448-B2 | C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors | Revolution Medicines, Inc. (US) | 2026-02-10 | — | — | US | disclosed |
| US-20250361181-A1 | DEGRADED AMINE SOLUTION AS PERFORMANCE ENHANCER | HSUSTAINABILITY GMBH (DE) | 2025-11-27 | — | — | US | disclosed |
| EP-4653426-A1 | PROTEOLYSIS TARGETING CHIMERA COMPOUND | Beijing Tide Pharmaceutical Co., Ltd. (CN) | 2025-11-26 | — | — | EP | disclosed |
| EP-4615573-A1 | GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS | Eli Lilly and Company (US) | 2025-09-17 | — | — | EP | disclosed |
| EP-0729472-A4 | PIPERIDINYLCAMPHORSULFONYL OXYTOCIN ANTAGONISTS | MERCK & CO INC (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0729472-A1 | PIPERIDINYLCAMPHORSULFONYL OXYTOCIN ANTAGONISTS | MERCK & CO. INC. (US) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995014025-A1 | PIPERIDINYLCAMPHORSULFONYL OXYTOCIN ANTAGONISTS | MERCK & CO., INC. (US) | 1995-05-26 | — | — | WO | disclosed |
| EP-0486280-A2 | Piperidinylcamphorsulfonyl oxytocin antagonists | MERCK & CO. INC. (US) | 1992-05-20 | — | — | EP | disclosed |
| US-4472498-A | BINDING PROTEIN | FUJI PHOTO FILM CO., LTD. (JP) | 1984-09-18 | — | — | US | disclosed |
| US-4233401-A | Antienzyme homogeneous competitive binding assay | SYVA COMPANY (US) | 1980-11-11 | — | — | US | disclosed |
| US-4191613-A | BONDED TO HAPTEN | SYVA COMPANY (US) | 1980-03-04 | — | — | US | disclosed |
| US-4168207-A | THYROXINE BINDING CAPACITY OF SERUM | SYVA COMPANY (US) | 1979-09-18 | — | — | US | disclosed |